Fanhua Inc (FANH) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2023 - CSIMarket
Fanhua Inc's ROA from the fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period
Return on Assets, Quarterly Results, Trends, Rankings, Statistics
What is Fanhua Inc's ROA in the fourth quarter of 2025?
Fanhua Inc recorded a cumulative net loss of $-325 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -147.27%.
However, within the Financial sector 1043 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 5094.
Fanhua Inc.: Navigating Leadership Changes Amid Market Challenges and Strategic InnovationsIn a dynamic landscape marked by both innovation and intensified competition, Fanhua Inc. an independent technology-driven financial services provider based in Guangzhou, China, is poised for transformation following significant leadership changes and external market pressures. As the company embarks on this pivotal journey, its revised strategy reflects an urgent need to recalibrate its business approaches in response to fluctuating financial performance.On October 9, 2024, Fanhua Inc. issued a corrected announcement that provided updated details regarding the newly appointed chairperson of the Board, Ms. Hang Suong Nguyen. Since June 2023, Nguyen has been the Vice President of WEALTH WILL LIMITED, where she has exhibited strong capabilities in steering operational strategies and capital deployment across emerging markets. Before her tenure at WEALTH WILL, she played a crucial role as Sales Director at Trustwell Far East Pte. Ltd. from late 2018 until May 2023, where her strategic insights significantly enhanced the company’s cross-border business operations. Nguyen holds a Bachelor s degree in International Business from Vietnam National University and an MBA from Hanoi University of Science and Technology, positioning her as a well-qualified leader to navigate the complexities of Fanhua s future endeavors.
Fanhua Inc. s Strategic Shift: Leadership Changes and Innovative Collaborations Shape the Future of Health Management in ChinaIn a significant update from Fanhua Inc. a prominent technology-driven financial services provider based in Guangzhou, China, the company s leadership dynamics are undergoing a major transformation. As of September 30, 2024, Ms. Hang Suong Nguyen has been appointed as the new Chairperson of the Board, ushering in what is anticipated to be a new era for the company. This leadership change comes at a pivotal time for Fanhua, as the company grapples with a fluctuating performance in the financial market. Financial Performance Under ScrutinyIn the fourth quarter of 2023, Fanhua Inc. reported a return on assets (ROA) of 7.09%. While this figure reflects an improvement from the dismal 2.29% reported in the previous quarter, it still falls below the company s average ROA of 7.92%. This concerning performance was further underscored by the fact that 63 other companies in the financial sector outperformed Fanhua in terms of ROA, indicating a broader need for strategic recalibration. The total ranking of Fanhua in the financial sector also deteriorated, slipping to 817th position compared to the prior quarter.
By Guangzhou, China , Sept. 06, 2024 Fanhua Inc. (Nasdaq: FANH), an eminent name in the technology-driven financial services sector in China, announced today that its wholly-owned subsidiary, Fanhua BluePlus Health Management Co. Ltd. (Fanhua BluePlus), has entered into a pivotal strategic cooperation agreement with Shanghai Biotecan Pharmaceuticals Co. Ltd. (Biotecan).In what is being hailed as a significant development in the realms of health management and pharmaceuticals, this alliance symbolizes a newfound synergy between tech-driven financial services and innovative pharmaceutical research. Bridging Financial Services with Health ManagementFanhua BluePlus, rooted in the bedrock of Fanhua Inc. s robust financial services traditions, operates with a focused mission on health management. Their strategic move to collaborate with Biotecan comes at a time when the intersections of technology, health, and finance are creating unprecedented opportunities for innovation and service enhancement.
Fanhua Inc. Grants Share Options to Key Employees to Foster Long-Term Success GUANGZHOU, China - Fanhua Inc., a leading independent technology-driven financial services provider in China, has recently announced that its board of directors has approved the grant of share options to certain key employees. This strategic move is aimed at incentivizing key talent and aligning their interests with the long-term success of the company. Fanhua Inc. has always recognized the importance of its employees in driving growth and maintaining a competitive edge in the market. By granting share options to key employees, the company aims to motivate and reward them for their valuable contributions. This initiative further emphasizes Fanhua s commitment to building a strong and capable team that can continue to drive innovation, growth, and achieve sustainable success.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
